(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems, Propharmex Company, India.
(1) Ali Osman Gürol, Istanbul University, Turkey.
(2) Krishnaswamy Sampathkumar, Meenakshi Mission Hospital and Research Centre, India.
(1) Oguz Karahan, Medical School of Alaaddin Keykubat University, Turkey.
(2) Walaa Fikry Elbossaty, Damietta University, Egypt.
Open Peer Review Policy: Click Here
Average Peer review marks at initial stage: 8/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_2 (Krishnaswamy Sampathkumar, India) | File 1 | NA
Stage 3 | Comment_Editor_1_v1 | File 1 | NA